Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Influenza

  Free Subscription


22.12.2025

1 Antimicrob Agents Chemother
1 Arch Virol
1 Biochemistry
1 Epidemiol Infect
1 J Clin Microbiol
1 J Gen Virol
2 J Infect Dis
2 JAMA
11 PLoS One
2 Proc Natl Acad Sci U S A
2 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. LEONARD VHJ, Vidales DB, Taft BR, Hesse MJ, et al
    Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.
    Antimicrob Agents Chemother. 2025 Dec 19:e0114925. doi: 10.1128/aac.01149.
    PubMed         Abstract available


    Arch Virol

  2. BEDAIR NM, Sakr MA, Mourad A, Eissa N, et al
    Genetic characterization of highly pathogenic avian influenza A/H5N8 virus isolated from commercial poultry farms in Egypt reveals zoonotic potential.
    Arch Virol. 2025;171:29.
    PubMed         Abstract available


    Biochemistry

  3. WESTMAN H, Hammarstrom P, Nystrom S
    SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis.
    Biochemistry. 2025;64:4818-4829.
    PubMed         Abstract available


    Epidemiol Infect

  4. STADHOUDERS L, Hoogteijling EM, Duijts L, Lebon A, et al
    Trends in asthma exacerbations in children before, during, and after the COVID-19 pandemic.
    Epidemiol Infect. 2025;153:e138.
    PubMed         Abstract available


    J Clin Microbiol

  5. BATAC ALR, Marks M, Tucker JD, Peeling RW, et al
    Syphilis self-testing and implications for syphilis control and prevention.
    J Clin Microbiol. 2025 Oct 21:e0098225. doi: 10.1128/jcm.00982.
    PubMed         Abstract available


    J Gen Virol

  6. EASTON V, McPhillie MJ, Santos IA, Hall P, et al
    Identification and characterization of candidate inhibitors of the SARS-CoV-2 nsp14 3'-5' exoribonuclease.
    J Gen Virol. 2025;106.
    PubMed         Abstract available


    J Infect Dis

  7. ZHU MQ, Kuan G, Maier HE, Lopez R, et al
    Stunting Increases Influenza Virus Shedding Duration in Preschool/School-Aged Children.
    J Infect Dis. 2025 Dec 18:jiaf641. doi: 10.1093.
    PubMed         Abstract available

  8. ROUPHAEL N, Tanios R, Traenkner J, Pauly MD, et al
    Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery Systems.
    J Infect Dis. 2025 Dec 16:jiaf603. doi: 10.1093.
    PubMed         Abstract available


    JAMA

  9. ZAMBON M, Hayden FG
    Influenza A(H3N2) Subclade K Virus: Threat and Response.
    JAMA. 2025 Dec 18. doi: 10.1001/jama.2025.25903.
    PubMed        

  10. SCHWEITZER K
    A New H3N2 Influenza Strain Is Raising Concerns About This Flu Season.
    JAMA. 2025 Dec 19. doi: 10.1001/jama.2025.25205.
    PubMed        


    PLoS One

  11. OH YJ, Rasul ME, Lim JI, Calabrese C, et al
    Targeting anger for COVID-19 prevention: The motivating role of anger on media use and vaccination intention.
    PLoS One. 2025;20:e0338183.
    PubMed         Abstract available

  12. MUIR T, Poudyal CS, De Lima R, Otaki F, et al
    Investigating organizational resilience in a medicine and health sciences university in United Arab Emirates.
    PLoS One. 2025;20:e0338728.
    PubMed         Abstract available

  13. CORTESI M, Pendenza F, Haddon E, Schiavio A, et al
    Can creative activities and mind-body practices help enhance well-being and mental health awareness? An exploratory qualitative study in UK higher education.
    PLoS One. 2025;20:e0338938.
    PubMed         Abstract available

  14. TINNERHOLM LJUNGBERG H, Wallberg M, Aboagye E, Bergstrom G, et al
    'Wish you were here': Managers' experiences of hybrid work in higher education.
    PLoS One. 2025;20:e0339120.
    PubMed         Abstract available

  15. BERCEANU C, Bertolotti F, Arshad N, Patrascu M, et al
    Understanding the mechanisms of infodemics: Equation-based vs. agent-based models.
    PLoS One. 2025;20:e0338614.
    PubMed         Abstract available

  16. ARAUJO JIF, Batista FAM, De Souto Medeiros MR, Sena BO, et al
    The use of social media as an influence on vaccination rates: A systematic review protocol.
    PLoS One. 2025;20:e0334114.
    PubMed         Abstract available

  17. FAN J, Yang Y, Zhang F, Wu X, et al
    Analysis of molecular mechanism of Chinese medicine Jinhong decoction (JHD) in synergistically treating sepsis and COVID-19 based on network pharmacology.
    PLoS One. 2025;20:e0339457.
    PubMed         Abstract available

  18. PARK J, Shon C
    The impact of COVID-19 on walking practices in Korea: Policy implications for Urban health and physical activity resilience.
    PLoS One. 2025;20:e0338875.
    PubMed         Abstract available

  19. BRUNEKREEF J, Teslya A, Buskens V, Nunner H, et al
    Impact of adherence and stringency on the effectiveness of lockdown measures: A modelling study.
    PLoS One. 2025;20:e0338818.
    PubMed         Abstract available

  20. GYAWALI N, Caragea D, Caragea C, Mohammad SM, et al
    The shifting landscape of vaccine discourse: Insights from a decade of pre- to post-COVID-19 vaccine posts on social media.
    PLoS One. 2025;20:e0337911.
    PubMed         Abstract available

  21. SCHWARTZ AR, Tate JP, Lehmann LS, King JT Jr, et al
    Advance directives prior to COVID-19 diagnosis in a United States national healthcare system.
    PLoS One. 2025;20:e0338825.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  22. DIAMANT ES, Yeh PJ
    Rapid morphological change in an urban bird due to COVID-19 restrictions.
    Proc Natl Acad Sci U S A. 2025;122:e2520996122.
    PubMed         Abstract available

  23. PETROVA B, Syphurs C, Culhane AJ, Chen J, et al
    MTHFR allele and one-carbon metabolic profile predict severity of COVID-19.
    Proc Natl Acad Sci U S A. 2025;122:e2509118122.
    PubMed         Abstract available


    Vaccine

  24. WANG L, Li L, Yang W, Pang X, et al
    Immunogenicity and safety of inactivated quadrivalent influenza vaccines in children aged 6-35 months: A multi-center, randomized, double-blind, active-controlled clinical trial.
    Vaccine. 2025;71:128113.
    PubMed         Abstract available

  25. YU S, Zheng B, Zhao J, Jiang L, et al
    Vaccine fatigue, perceived risk and trust: Unraveling the motivational drivers of influenza vaccination in Chinese adults using the COM-B model.
    Vaccine. 2025;72:128112.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.